Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.860
+0.082 (10.60%)
At close: Apr 26, 2024, 4:00 PM
0.856
-0.005 (-0.53%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
1,8513,5803,27912,355--
Market Cap Growth
-9.20%-73.46%---
Enterprise Value
1,1292,8582,37610,827-364-479
PE Ratio
-4.01-4.01-1.56-6.75--
PS Ratio
7.3614.246.8639.37--
PB Ratio
1.693.261.898.21--
P/FCF Ratio
-10.79-10.79-10.77-39.81--
P/OCF Ratio
-12.12-12.12-13.00-48.68--
EV/Sales Ratio
4.4911.374.9734.50-4.75-8.83
EV/EBITDA Ratio
-3.60-3.60-1.16-6.013.364.51
EV/EBIT Ratio
-3.20-3.20-1.12-5.922.984.09
EV/FCF Ratio
-8.61-8.61-7.80-34.891.887.15
Debt / Equity Ratio
0.200.200.240.010.040.03
Debt / EBITDA Ratio
-0.28-0.28-0.20-0.01-0.15-0.16
Debt / FCF Ratio
-0.67-0.67-1.36-0.07-0.09-0.25
Quick Ratio
5.875.878.0812.515.5012.55
Current Ratio
6.116.118.3812.795.8312.77
Asset Turnover
0.120.120.230.230.11-
Interest Coverage
-9600.51-9600.51-19998.58-770.82-51.29-48.28
Return on Equity (ROE)
-65.40%-65.40%-133.90%-192.90%-26.50%-
Return on Assets (ROA)
-42.50%-42.50%-99.50%-134.30%-18.40%-
Return on Capital (ROIC)
-65.54%-65.54%-102.76%-119.69%-28.67%-14.04%
Earnings Yield
-48.23%-24.94%-64.20%-14.81%--
FCF Yield
-17.93%-9.27%-9.29%-2.51%--
Buyback Yield / Dilution
-15.75%-15.75%-23.48%-6.72%-10.95%-
Total Shareholder Return
-15.75%-15.75%-23.48%-6.72%-10.95%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).